Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
ADVANCED SEARCH
Log in
Top
World Journal of Surgical Oncology
Published in:

Open Access 01-12-2024 | Research

Postoperative follow-up compliance and survival analysis in pseudomyxoma peritonei patients treated with CRS and HIPEC: a six-year retrospective study

Authors: Guang Yang, Qi Liu, Na Wang, Guanying Yu, Peiming Guo, Lan Ye

Published in: World Journal of Surgical Oncology | Issue 1/2024

Login to get access

Abstract

Background

PMP is a rare clinical syndrome characterized by the accumulation of mucinous material in the peritoneal cavity. The combination of CRS and HIPEC is the standard treatment, known to improve survival outcomes. However, follow-up adherence is critical for early detection of recurrence and extending survival. This study is the first to specifically investigate postoperative follow-up adherence in PMP patients treated with CRS and HIPEC.

Aims

To explore the socio-demographic and clinical determinants of follow-up adherence and its impact on survival in PMP patients treated with CRS and HIPEC.

Methods

This single-center, six-year retrospective study included 111 PMP patients who underwent CRS and HIPEC. Patients were categorized into compliant (control) and non-compliant (study) groups. Follow-up was initiated by the physician, with patients returning for regular visits as recommended. Kaplan-Meier analysis was used to evaluate survival outcomes, while univariate analysis identified factors influencing follow-up adherence.

Results

Among 111 patients, 32 died by August 2024, with 1-, 3-, and 5-year survival rates of 88%, 66%, and 53%, respectively. High PCI scores (P < 0.001) and poorer histopathological types (P = 0.002) were significant predictors of reduced survival. Non-compliance with follow-up showed a trend toward decreased survival (P = 0.07). Significant risk factors for non-compliance included lower ASA scores (P = 0.020), middle- and low-income levels (P = 0.034), and parental survival status (P = 0.003). Middle- and low-income patients also experienced longer delays in seeking medical advice and had fewer cases detected through routine health screenings (P = 0.019).

Conclusions

Follow-up compliance has a potential impact on survival outcomes in PMP patients treated with CRS and HIPEC. Socio-demographic factors significantly influence adherence, highlighting the need for tailored interventions to enhance patient management.
Literature
1.
Martínez-Quintanilla J, Cabot D, Sabia D, Arqués O, Vergés J, Chicote I et al. Precision oncology and systemic targeted therapy in Pseudomyxoma Peritonei. Clin Cancer Res 2024.
2.
Yano H, Gohda Y, Moran BJ, Suda R, Kokudo N. Long-term outcomes and survival analysis of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei at a newly established peritoneal malignancy centre in Japan. Ann Gastroenterol Surg. 2024;8(4):701–10.CrossRefPubMedPubMedCentral
3.
Bai M, Wang S, Liang G, Cai Y, Lu Y, Hou N, et al. Nomogram to Predict Incomplete Cytoreduction for Pseudomyxoma Peritonei. Ann Surg Oncol. 2022;29(2):885–92.CrossRefPubMed
4.
Xiao K, Yeung JC, Bolger JC. The safety and acceptability of using telehealth for follow-up of patients following cancer surgery: a systematic review. Eur J Surg Oncol. 2023;49(1):9–15.CrossRefPubMed
5.
Dao D, Najor AJ, Sun PY, Farrokhyar F, Moir CR, Ishitani MB. Follow-up outcomes of pediatric patients who underwent surgical resection for lipoblastomas or lipoblastomatosis: a single-institution experience with a systematic review and meta-analysis. Pediatr Surg Int. 2020;36(3):341–55.CrossRefPubMed
6.
Qiu WW, Chen QY, Zheng WZ, He QC, Huang ZN, Xie JW, et al. Postoperative follow-up for gastric cancer needs to be individualized according to age, tumour recurrence pattern, and recurrence time. Eur J Surg Oncol. 2022;48(8):1790–8.CrossRefPubMed
7.
Mittal R, Chandramohan A, Moran B. Pseudomyxoma peritonei: natural history and treatment. Int J Hyperth. 2017;33(5):511–9.CrossRef
8.
Carr NJ, Cecil TD, Mohamed F, Sobin LH, Sugarbaker PH, González-Moreno S, et al. A Consensus for classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi process. Am J Surg Pathol. 2016;40(1):14–26.CrossRefPubMed
9.
Zeng H, Ran X, An L, Zheng R, Zhang S, Ji JS, et al. Disparities in stage at diagnosis for five common cancers in China: a multicentre, hospital-based, observational study. Lancet Public Health. 2021;6(12):e877–87.CrossRefPubMed
10.
Li D, Lei HK, Shu XL, Zhang X, Tu HL, Wang F, et al. Association of public health insurance with cancer-specific mortality risk among patients with nasopharyngeal carcinoma: a prospective cohort study in China. Front Public Health. 2023;11:1020828.CrossRefPubMedPubMedCentral
11.
Baratti D, Kusamura S, Guaglio M, Milione M, Pietrantonio F, Cavalleri T, et al. Relapse of Pseudomyxoma Peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: pattern of failure, Clinical Management and outcomes. Ann Surg Oncol. 2023;30(1):404–14.CrossRefPubMed
12.
Liang L, Fang J, Han X, Zhai X, Song Y, Lu Y, et al. Prognostic value of CEA, CA19-9, CA125, CA724, and CA242 in serum and ascites in Pseudomyxoma Peritonei. Front Oncol. 2021;11:594763.CrossRefPubMedPubMedCentral
13.
Hotta M, Minamimoto R, Gohda Y, Tajima T, Kiyomatsu T, Yano H. Pseudomyxoma peritonei: visceral scalloping on CT is a predictor of recurrence after complete cytoreductive surgery. Eur Radiol. 2020;30(8):4193–200.CrossRefPubMed
14.
Becqué YN, van der Wel M, Aktan-Arslan M, Driel AGV, Rietjens JAC, van der Heide A, et al. Supportive interventions for family caregivers of patients with advanced cancer: a systematic review. Psychooncology. 2023;32(5):663–81.CrossRefPubMed
15.
Yang L, Liu J, Liu Q, Wang Y, Yu J, Qin H. The relationships among symptom experience, family support, health literacy, and fear of progression in advanced lung cancer patients. J Adv Nurs. 2023;79(9):3549–58.CrossRefPubMed
16.
Stanley NB, Quinn G, Reed D, Galligan A, Reblin M. Support for Young Adult Cancer patients: perspectives of patients and their mothers. J Cancer Educ. 2019;34(6):1097–102.CrossRefPubMed
17.
Delhorme JB, Villeneuve L, Bouché O, Averous G, Dohan A, Gornet JM, et al. Appendiceal tumors and pseudomyxoma peritonei: French Intergroup Clinical Practice guidelines for diagnosis, treatments and follow-up (RENAPE, RENAPATH, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR). Dig Liver Dis. 2022;54(1):30–9.CrossRefPubMed
18.
Lyu MM, Siah RC, Lam ASL, Cheng KKF. The effect of psychological interventions on fear of cancer recurrence in breast cancer survivors: a systematic review and meta-analysis. J Adv Nurs. 2022;78(10):3069–82.CrossRefPubMed
19.
Cheng KKF, Lim YTE, Koh ZM, Tam WWS. Home-based multidimensional survivorship programmes for breast cancer survivors. Cochrane Database Syst Rev. 2017;8(8):Cd011152.PubMed
20.
Li J, Peng X, Su Y, He Y, Zhang S, Hu X. Effectiveness of psychosocial interventions for posttraumatic growth in patients with cancer: a meta-analysis of randomized controlled trials. Eur J Oncol Nurs. 2020;48:101798.CrossRefPubMed
21.
Serrano-Ripoll MJ, Zamanillo-Campos R, Fiol-DeRoque MA, Castro A, Ricci-Cabello I. Impact of Smartphone App-based psychological interventions for reducing depressive symptoms in people with Depression: systematic literature review and Meta-analysis of Randomized controlled trials. JMIR Mhealth Uhealth. 2022;10(1):e29621.CrossRefPubMedPubMedCentral
Metadata
Title
Postoperative follow-up compliance and survival analysis in pseudomyxoma peritonei patients treated with CRS and HIPEC: a six-year retrospective study
Authors
Guang Yang
Qi Liu
Na Wang
Guanying Yu
Peiming Guo
Lan Ye
Publication date
01-12-2024
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2024
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-024-03598-w

Other articles of this Issue 1/2024

Management strategy for children with ovarian immature teratoma: results from a tertiary pediatric oncology center

CD47—a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features

Clinical implications of pediatric biliary intraepithelial neoplasia diagnosed from a choledochal cyst specimen

Treatment in certified cancer centers is related to better survival in patients with colon and rectal cancer: evidence from a large German cohort study

Residual biliary intraepithelial neoplasia without malignant transformation at resection margin for perihilar cholangiocarcinoma does not require expanded resection: a dual center retrospective study

Integrated bioinformatics analysis identifies PCSK9 as a prognosticator correlated with lipid metabolism in pancreatic adenocarcinoma

SPONSORED

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

  • Webinar | 06-02-2024 | 20:00 (CET)

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by:
  • Viatris
Developed by: Springer Healthcare
Watch now
Image Credits